A systematic review of emergency department point-of-care cardiac markers and efficiency measures

Point of Care

Volumn 8, Issue 3, 2009, Pages 121-125

  Storrow, Alan B ^a,b   Lyon, Jennifer A ^b   Porter, Matthew W ^a   Zhou, Chuan ^c   Han, Jin Ho ^a   Lindsell, Christopher J ^d  

^a Department of Emergency Medicine ^*  (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Acute coronary syndrome; Cardiac biomarkers; Chest pain; Diagnostic testing; Point of care; Systematic review

Indexed keywords

EID: 70249123145     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/POC.0b013e3181b316b9     Document Type: Article

References (23)

1. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110(9):e82-e292.
2. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarctionYsummary article: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40(7):1366-1374.
3. Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical authors' Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem. 2007;53(4):552-574.
4. Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem. 2007;115(13):e356-e375.
5. Christenson RH, Apple FS, Cannon CP, et al. Biomarkers of acute coronary syndromes and heart failure. Available at: http://www.aacc.org/members/nacb/ LMPG/OnlineGuide/PublishedGuidelines/ACSHeart/Pages/default.aspx. Accessed November 17, 2008.
6. Ryan RJ, Lindsell CJ, Hollander JE, et al. A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: The Disposition Impacted by Serial Point of Care Markers in Acute Coronary Syndromes (DISPO-ACS) trial. Ann Emerg Med. 2009;53(3):321-328.
7. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999; 354(9193):1896-1900.
8. Altinier S, Zaninotto M, Mion M, et al. Point-of-care testing of cardiac markers: Results from an experience in an emergency department. Clinica Chimica Acta. 2001;311(1):67-72.
9. Apple FS, Chung AY, Kogut ME, et al. Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit. Clinica Chimica Acta. 2006;370(1-2):191-195.
10. Caragher TE, Fernandez BB, Jacobs FL, et al. Evaluation of quantitative cardiac biomarker point-of-care testing in the emergency department. J Emerg Med. 2002;22(1):1-7.
11. Di Serio F, Antonelli G, Trerotoli P, et al. Appropriateness of point-of-care testing (POCT) in an emergency department. Clinica Chimica Acta. 2003;333(2):185-189.
12. Lee-Lewandrowski E, Corboy D, Lewandrowski K, et al. Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center. Impact on test turnaround time and patient emergency department length of stay. Arch Pathol Lab Med. 2003;127(4):456-460.
13. McCord J, Nowak RM, McCullough PA, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation. 2001;104(13): 1483-1488.
14. Newby LK, Storrow AB, Gibler WB, et al. Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation. 2001;103(14):1832-1837.
15. Novis DA, Jones BA, Dale JC, et al. Biochemical markers of myocardial injury test turnaround time: A College of American Pathologists Q-Probes Study of 7020 troponin and 4368 creatine kinase-MB determinations in 159 institutions. Arch Pathol Lab Med. 2004;128(2): 158-164.
16. Singer AJ, Ardise J, Gulla J, et al. Point-of-care testing reduces length of stay in emergency department chest pain patients. Ann Emerg Med. 2005;45(6):587-591.
17. Storrow AB, Lindsell CJ, Collins SP, et al. Emergency department multimarker point-of-care testing reduces time to cardiac marker results without loss of diagnostic accuracy. Point of Care. 2006;5(3): 132-136.
18. Cramer GE, Kievit PC, Brouwer MA, et al. Lack of concordance between a rapid bedside and conventional laboratory method of cardiac troponin testing: Impact on risk stratification of patients suspected of acute coronary syndrome. Clinica Chimica Acta. 2007;381(2):164-166.
19. Renaud B, Maison P, Ngako A, et al. Impact of point-of-care testing in the emergency department evaluation and treatment of patients with suspected acute coronary syndromes. Acad Emerg Med. 2008;15(3): 216-224.
20. Storrow AB, Zhou C, Gaddis G, et al. Decreasing lab turnaround time improves emergency department throughput and decreases emergency medical services diversion: A simulation model. Acad Emerg Med. 2008;15(11):1130-1135.
21. Parvin CA, Lo SF, Deuser SM, et al. Impact of point-of-care testing on patients' length of stay. Clin Chem. 1996;42(5):711-717.
22. Singer AJ, Viccellio P, Thode HC Jr, et al. Introduction of a stat laboratory reduces emergency department length of stay. Acad Emerg Med. 2008;15(4):324-328.
23. Goodacre S. Randomised assessment of treatment using panel assay of cardiac markers. Available at: http://www.sheffield.ac.uk/ratpac/. Accessed November 18, 2008.